Cycloartane-type triterpenoids from Combretum quadrangulare Kurz with PCSK9 secretion inhibitory activities
Phytochemistry · 2025-02 · 230 · 114330
DOI: 10.1016/j.phytochem.2024.114330 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytochemistry, 2025-02. Verfasst von Chae-Yeong An und 10 weiteren Autor:innen. Beteiligte Einrichtung: Natural Product Research Institute and Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, 08826, R…. Hauptthemen laut MEDLINE: Triterpenes, Proprotein Convertase 9, PCSK9 Inhibitors, Combretum. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Institute of Biological Resources, National Research Foundation of Korea.
Abstract (Originalsprache)
Nine previously undescribed (1-9) and seven known (10-16) cycloartane-type triterpenoids were isolated and characterized from Combretum quadrangulare Kurz using physicochemical and spectroscopic methods. The absolute configurations of these compounds were determined through modified Mosher's method and quantum chemical calculation of electronic circular dichroism (ECD) and vibrational circular dichroism (VCD) spectra. Their inhibitory activities against PCSK9 secretion were assessed, and a plausible structure-activity relationship was delineated. Compounds 2, 14, and 15 exhibited notable inhibitory effects on PCSK9 mRNA and protein levels, and significant PCSK9 mRNA inhibition was observed when co-treated with atorvastatin. Compound 15 showed the most potent activity, markedly enhancing LDL uptake compared to the negative control. In vivo pharmacokinetic studies confirmed that compound 15 exhibited higher distribution in the liver than plasma, where PCSK9 is predominantly synthesized. These findings emphasize the potential significance of the cycloartane-type triterpenoid scaffold in discovering PCSK9 inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Natural Product Research Institute and Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
- College of Pharmacy and Integrated Research Institute for Drug Development, Dongguk University_Seoul, 32 Dongguk-lo, Ilsandong-gu, Goyang-si, Gyeonggi-do, 10326, Republic of Korea.
- Department of Plant Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, 02841, Republic of Korea.
- Dalat University, Center for Biodiversity and Climate Change Research, Phu Dong Thien Vuong 01, Dalat City, Lam Dong Province, Viet Nam.
- Species Diversity Research Division, National Institute of Biological Resources, Incheon, 22689, Republic of Korea.
- Natural Product Research Institute and Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea. Electronic address: ywchin@snu.ac.kr.
Förderung
- National Institute of Biological Resources
- National Research Foundation of Korea
Zitieren
APA
An, C. Y., Pel, P., Bae, M., Park, C. W., Kwon, H., Lee, H. S., Dung, L. V., Kim, C., Lee, D., Choi, Y. H., & Chin, Y. W. (2025). Cycloartane-type triterpenoids from Combretum quadrangulare Kurz with PCSK9 secretion inhibitory activities. Phytochemistry, 230, 114330. https://doi.org/10.1016/j.phytochem.2024.114330
Vancouver
An CY, Pel P, Bae M, Park CW, Kwon H, Lee HS, et al. Cycloartane-type triterpenoids from Combretum quadrangulare Kurz with PCSK9 secretion inhibitory activities. Phytochemistry. 2025;230:114330. doi:10.1016/j.phytochem.2024.114330
BibTeX
@article{An2025,
author = {An, Chae-Yeong and Pel, Pisey and Bae, Mingoo and Park, Chan-Woong and Kwon, Haeun and Lee, Hyun Suk and Dung, Luong Van and Kim, Changmu and Lee, Dongho and Choi, Young Hee and Chin, Young-Won},
title = {Cycloartane-type triterpenoids from Combretum quadrangulare Kurz with PCSK9 secretion inhibitory activities},
journal = {Phytochemistry},
year = {2025},
volume = {230},
pages = {114330},
doi = {10.1016/j.phytochem.2024.114330}
}
EUVIMED